Noxopharm has an EPS of $-0.0515. In 2022, the company made an earnings per share (EPS) of $-0.0641. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.0515 | -19.66% |
2022 | -$0.0641 | 81.07% |
2021 | -$0.0354 | 1670.00% |
2020 | -$0.002 | - |